173 related articles for article (PubMed ID: 36776544)
21. The Role of C-Reactive Protein in Kidney, Bladder, and Prostate Cancers.
O'Brian D; Prunty M; Hill A; Shoag J
Front Immunol; 2021; 12():721989. PubMed ID: 34512646
[TBL] [Abstract][Full Text] [Related]
22. Serum C-reactive protein acted as a prognostic biomarker for overall survival in metastatic prostate cancer patients.
Xu L; Zhao Q; Huang S; Li S; Wang J; Li Q
Tumour Biol; 2015 Feb; 36(2):669-73. PubMed ID: 25286759
[TBL] [Abstract][Full Text] [Related]
23. A predictive role of C-reactive protein in colorectal cancer risk: an updated meta-analysis from 780,985 participants and 11,289 cancer cases.
Han L; Guo Y; Ren D; Hui H; Li N; Xie X
Int J Colorectal Dis; 2023 May; 38(1):121. PubMed ID: 37160817
[TBL] [Abstract][Full Text] [Related]
24. C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial.
Beer TM; Lalani AS; Lee S; Mori M; Eilers KM; Curd JG; Henner WD; Ryan CW; Venner P; Ruether JD; Chi KN;
Cancer; 2008 Jun; 112(11):2377-83. PubMed ID: 18428198
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis.
Yu A; Guo K; Qin Q; Xing C; Zu X
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 33635319
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of C-reactive protein in metastatic prostate cancer: a systematic review and meta-analysis.
Rocha P; Morgan CJ; Templeton AJ; Pond GR; Naik G; Sonpavde G
Oncol Res Treat; 2014; 37(12):772-6. PubMed ID: 25531724
[TBL] [Abstract][Full Text] [Related]
27. C-reactive protein and procalcitonin levels in prostate cancer.
Ilktac A; Kalkan S; Caliskan S
Int J Clin Pract; 2021 Apr; 75(4):e13935. PubMed ID: 33326672
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of C-reactive protein in gastric cancer: a meta-analysis.
Yu Q; Yu XF; Zhang SD; Wang HH; Wang HY; Teng LS
Asian Pac J Cancer Prev; 2013; 14(10):5735-40. PubMed ID: 24289571
[TBL] [Abstract][Full Text] [Related]
29. Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer.
Mikkelsen MK; Lindblom NAF; Dyhl-Polk A; Juhl CB; Johansen JS; Nielsen D
Crit Rev Clin Lab Sci; 2022 Nov; 59(7):480-500. PubMed ID: 35403550
[TBL] [Abstract][Full Text] [Related]
30. Do preoperative serum C-reactive protein levels predict the definitive pathological stage in patients with clinically localized prostate cancer?
Schnoeller TJ; Steinestel J; Steinestel K; Jentzmik F; Schrader AJ
Int Urol Nephrol; 2015 May; 47(5):765-70. PubMed ID: 25787073
[TBL] [Abstract][Full Text] [Related]
31. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.
Allin KH; Nordestgaard BG
Crit Rev Clin Lab Sci; 2011; 48(4):155-70. PubMed ID: 22035340
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis.
Zhou L; Cai X; Liu Q; Jian ZY; Li H; Wang KJ
Sci Rep; 2015 Aug; 5():12733. PubMed ID: 26235332
[TBL] [Abstract][Full Text] [Related]
33. Effect of obesity on the prognosis and recurrence of prostate cancer after radical prostatectomy: a meta-analysis.
Luo R; Chen Y; Ran K; Jiang Q
Transl Androl Urol; 2020 Dec; 9(6):2713-2722. PubMed ID: 33457243
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of baseline C-reactive protein in diffuse large B-cell lymphoma: a systematic review and meta-analysis.
Huang Z; Wang K; Huang S; Lu Q
Transl Cancer Res; 2023 Aug; 12(8):2169-2180. PubMed ID: 37701105
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study.
Stikbakke E; Richardsen E; Knutsen T; Wilsgaard T; Giovannucci EL; McTiernan A; Eggen AE; Haugnes HS; Thune I
Int J Cancer; 2020 Jul; 147(1):84-92. PubMed ID: 31583707
[TBL] [Abstract][Full Text] [Related]
36. Pretransplant C-reactive protein as a prognostic marker in allogeneic stem cell transplantation: A PRISMA-compliant meta-analysis.
Wu P; Liang W; Chen X; Chen L; Yang X; Yan Z; Wang W
Medicine (Baltimore); 2019 Feb; 98(8):e14474. PubMed ID: 30813150
[TBL] [Abstract][Full Text] [Related]
37. Association between peripheral blood levels of C-reactive protein and Autism Spectrum Disorder in children: A systematic review and meta-analysis.
Yin F; Wang H; Liu Z; Gao J
Brain Behav Immun; 2020 Aug; 88():432-441. PubMed ID: 32272227
[TBL] [Abstract][Full Text] [Related]
38. A systematic review of the association between circulating concentrations of C reactive protein and cancer.
Heikkilä K; Ebrahim S; Lawlor DA
J Epidemiol Community Health; 2007 Sep; 61(9):824-33. PubMed ID: 17699539
[TBL] [Abstract][Full Text] [Related]
39. Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.
Heidenreich A; Fossati N; Pfister D; Suardi N; Montorsi F; Shariat S; Grubmüller B; Gandaglia G; Briganti A; Karnes RJ
Eur Urol Oncol; 2018 May; 1(1):46-53. PubMed ID: 31100228
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
